Company
Headquarters: New Taipei City, Taiwan
TW$1.48 Billion
TWD as of Jan. 1, 2024
US$48.2 Million
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $461.52 B |
| Vertex Pharmaceuticals Incorporated | $107.23 B |
| Regeneron Pharmaceuticals, Inc. | $100.01 B |
| CSL Limited | $94.74 B |
| Marinomed Biotech AG | $73.23 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Genomics BioSci & Tech Co.,Ltd. operates as a genome sequencing company. It offers regular DNA, complex sequence, and TAF certificated sequencing services, as well as free sequencing primer and primer walking services; peptide, gene, and oligo synthesis services; and sample preparation, gene expression analysis, genotyping analysis, DNA methylation analysis, and microbial identification services. The company also provides genome level, targeted, gene regulation, and metagenomic sequencing services; third generation sequencing services; sequencing platforms and workflow; and non-invasive prenatal test, spinal muscular atrophy carrier screening, and fragile X syndrome premutation screening services. In addition, it offers EndoPredict genetic testing, gene testing services for cancer target-drug and cancer, and cancer panel services. The company was founded in 2001 and is based in New Taipei City, Taiwan.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Genomics BioSci & Tech. Co.,Ltd. has the following listings and related stock indices.
Stock: TWSE: 4195 wb_incandescent